{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T23:54:03Z","timestamp":1785196443614,"version":"3.55.0"},"reference-count":49,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2020.8716","type":"journal-article","created":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T12:13:47Z","timestamp":1588680827000},"page":"219-226","source":"Crossref","is-referenced-by-count":8,"title":["Comparison of rapamycin and methylprednisolone for treating inflammatory muscle disease in a murine model of experimental autoimmune myositis"],"prefix":"10.3892","volume":"20","author":[{"given":"Juan","family":"Kang","sequence":"first","affiliation":[{"name":"Department of Neurology, Xijing Hospital, The Fourth Military Medical University, Xincheng, Xi'an, Shaanxi 710032, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyun","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xijing Hospital, The Fourth Military Medical University, Xincheng, Xi'an, Shaanxi 710032, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xijing Hospital, The Fourth Military Medical University, Xincheng, Xi'an, Shaanxi 710032, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojia","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xijing Hospital, The Fourth Military Medical University, Xincheng, Xi'an, Shaanxi 710032, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xijing Hospital, The Fourth Military Medical University, Xincheng, Xi'an, Shaanxi 710032, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongge","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xijing Hospital, The Fourth Military Medical University, Xincheng, Xi'an, Shaanxi 710032, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2020,5,5]]},"reference":[{"key":"key20200713004456_b1-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1177\/1756285608097463","article-title":"Therapeutic advances and future prospects in immune-mediated inflammatory myopathies","volume":"1","author":"Dalakas","year":"2008","journal-title":"Ther Adv Neurol Disord"},{"key":"key20200713004456_b2-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas","year":"2003","journal-title":"Lancet"},{"key":"key20200713004456_b3-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1097\/00019052-200110000-00007","article-title":"Inflammatory muscle diseases","volume":"14","author":"Hilton-Jones","year":"2001","journal-title":"Curr Opin Neurol"},{"key":"key20200713004456_b4-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/s0889-857x(02)00021-2","article-title":"Idiopathic inflammatory myopathies: Epidemiology, classification, and diagnostic criteria","volume":"28","author":"Mastaglia","year":"2002","journal-title":"Rheum Dis Clin North Am"},{"issue":"16","key":"key20200713004456_b5-etm-0-0-8716","doi-asserted-by":"publisher","DOI":"10.1186\/2044-5040-4-16","article-title":"The injury-induced myokine insulin-like 6 is protective in experimental autoimmune myositis","volume":"4","author":"Zeng","year":"2014","journal-title":"Skelet Muscle"},{"key":"key20200713004456_b6-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/s0022-510x(97)00148-2","article-title":"Myosin-Induced autoimmune polymyositis in the rat","volume":"151","author":"Kojima","year":"1997","journal-title":"J Neurol Sci"},{"key":"key20200713004456_b7-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12016-015-8513-8","article-title":"The clinical features of myositis-associated autoantibodies: A review","volume":"52","author":"Gunawardena","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"key20200713004456_b8-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1136\/jnnp.68.4.472","article-title":"Myopathy with anti-Jo-1 antibodies: Pathology in perimysium and neighbouring muscle fibres","volume":"68","author":"Mozaffar","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key20200713004456_b9-etm-0-0-8716","first-page":"646","article-title":"Subcutaneous immunoglobulin G in idiopathic inflammatory myopathies: Therapeutic implications","volume":"16","author":"Gelardi","year":"2014","journal-title":"Isr Med Assoc J"},{"key":"key20200713004456_b10-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.revmed.2013.09.008","article-title":"Therapeutic strategy in inflammatory myopathies (polymyositis, dermatomyositis, overlap myositis, and immune-mediated necrotizing myopathy)","volume":"35","author":"Tournadre","year":"2014","journal-title":"Rev Med Interne"},{"key":"key20200713004456_b11-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jaut.2009.06.003","article-title":"Treatment with rapamycin ameliorates clinical and histological signs of protracted relapsing experimental allergic encephalomyelitis in dark agouti rats and induces expansion of peripheral CD4+CD25+Foxp3+ regulatory T cells","volume":"33","author":"Donia","year":"2009","journal-title":"J Autoimmun"},{"key":"key20200713004456_b12-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.3892\/mmr.2016.5392","article-title":"Rapamycin ameliorates CCl4-induced liver fibrosis in mice through reciprocal regulation of the Th17\/Treg cell balance","volume":"14","author":"Gu","year":"2016","journal-title":"Mol Med Rep"},{"key":"key20200713004456_b13-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3760\/cma.j.issn.1007-3418.2016.05.011","article-title":"Preventive and therapeutic effects of rapamycin against autoimmune hepatitis and liver fibrosis and possible mechanisms","volume":"24","author":"Li","year":"2016","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"E142","key":"key20200713004456_b14-etm-0-0-8716","doi-asserted-by":"publisher","DOI":"10.25011\/cim.v37i3.21381","article-title":"Rapamycin reduces renal hypoxia, interstitial inflammation and fibrosis in a rat model of unilateral ureteral obstruction","volume":"37","author":"Liu","year":"2014","journal-title":"Clin Invest Med"},{"key":"key20200713004456_b15-etm-0-0-8716","first-page":"141","article-title":"Th1, Th2 and Th17 cytokine profile in patients with multiple sclerosis following treatment with rapamycin","volume":"13","author":"Salehi","year":"2016","journal-title":"Iran J Immunol"},{"key":"key20200713004456_b16-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1159\/000369680","article-title":"Rapamycin attenuates aldosterone-induced tubulointerstitial inflammation and fibrosis","volume":"35","author":"Wang","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"key20200713004456_b17-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/s1499-3872(12)60149-0","article-title":"Rapamycin combined with allogenic immature dendritic cells selectively expands CD4+CD25+Foxp3+ regulatory T cells in rats","volume":"11","author":"Wang","year":"2012","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"key20200713004456_b18-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1097\/00002281-200307000-00010","article-title":"Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis","volume":"15","author":"Gambineri","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"key20200713004456_b19-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.cell.2014.07.030","article-title":"Function of a Foxp3 cis-element in protecting regulatory T cell identity","volume":"158","author":"Li","year":"2014","journal-title":"Cell"},{"key":"key20200713004456_b20-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1146\/annurev.immunol.18.1.423","article-title":"Regulatory T cells in autoimmmunity","volume":"18","author":"Shevach","year":"2000","journal-title":"Ann Rev Immunol"},{"key":"key20200713004456_b21-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1084\/jem.20020090","article-title":"CD4(+)CD25(+) immunoregulatory T cells: New therapeutics for graft-versus-host disease","volume":"196","author":"Cohen","year":"2002","journal-title":"J Exp Med"},{"key":"key20200713004456_b22-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"989","DOI":"10.2353\/ajpath.2009.080422","article-title":"Role of regulatory T cells in a new mouse model of experimental autoimmune myositis","volume":"174","author":"Allenbach","year":"2009","journal-title":"Am J Pathol"},{"issue":"e74450","key":"key20200713004456_b23-etm-0-0-8716","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0074450","article-title":"Beneficial role of rapamycin in experimental autoimmune myositis","volume":"8","author":"Prevel","year":"2013","journal-title":"PLoS One"},{"key":"key20200713004456_b24-etm-0-0-8716","first-page":"14457","article-title":"Development of an improved animal model of experimental autoimmune myositis","volume":"8","author":"Kang","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"key20200713004456_b25-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/s0166-4328(01)00231-5","article-title":"A comparison of 129S2\/SvHsd and C57BL\/6JOlaHsd mice on a test battery assessing sensorimotor, affective and cognitive behaviours: Implications for the study of genetically modified mice","volume":"124","author":"Contet","year":"2001","journal-title":"Behav Brain Res"},{"key":"key20200713004456_b26-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/s0165-5728(99)00087-9","article-title":"C-Protein in the skeletal muscle induces severe autoimmune polymyositis in lewis rats","volume":"98","author":"Kohyama","year":"1999","journal-title":"J Neuroimmunol"},{"key":"key20200713004456_b27-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jneuroim.2007.08.013","article-title":"Characterization of pathogenic T cells and autoantibodies in C-protein-induced autoimmune polymyositis","volume":"190","author":"Matsumoto","year":"2007","journal-title":"J Neuroimmunol"},{"key":"key20200713004456_b28-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1093\/intimm\/dxv001","article-title":"Experimental myositis inducible with transfer of dendritic cells presenting a skeletal muscle C protein-derived CD8 epitope peptide","volume":"27","author":"Okiyama","year":"2015","journal-title":"Int Immunol"},{"key":"key20200713004456_b29-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1365-2567.2006.02321.x","article-title":"Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: The role of T regulatory cells","volume":"117","author":"Taylor","year":"2006","journal-title":"Immunology"},{"key":"key20200713004456_b30-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/2211-5463.12039","article-title":"MTOR inhibition by rapamycin increases ceramide synthesis by promoting transforming growth factor-\u03b21\/Smad signaling in the skin","volume":"6","author":"Yamane","year":"2016","journal-title":"FEBS Open Bio"},{"key":"key20200713004456_b31-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1084\/jem.184.6.2417","article-title":"A role for endogenous transforming growth factor beta 1 in langerhans cell biology: The skin of transforming growth factor beta 1 null mice is devoid of epidermal langerhans cells","volume":"184","author":"Borkowski","year":"1996","journal-title":"J Exp Med"},{"key":"key20200713004456_b32-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1189\/jlb.0503228","article-title":"The role of the combination of IL-2 and TGF-beta or IL-10 in the generation and function of CD4+ CD25+ and CD8+ regulatory T cell subsets","volume":"74","author":"Horwitz","year":"2003","journal-title":"J Leukoc Biol"},{"key":"key20200713004456_b33-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1093\/intimm\/dxh165","article-title":"Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells","volume":"16","author":"Yagi","year":"2004","journal-title":"Int Immunol"},{"key":"key20200713004456_b34-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jneuroim.2010.03.013","article-title":"FOXP3+ T regulatory cells in idiopathic inflammatory myopathies","volume":"225","author":"Waschbisch","year":"2010","journal-title":"J Neuroimmunol"},{"key":"key20200713004456_b35-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1080\/08916930802282651","article-title":"Quantification and molecular characterization of regulatory T cells in connective tissue diseases","volume":"42","author":"Banica","year":"2009","journal-title":"Autoimmunity"},{"key":"key20200713004456_b36-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"986","DOI":"10.2741\/3657","article-title":"Th 17 cells interplay with Foxp3+ Tregs in regulation of inflammation and autoimmunity","volume":"15","author":"Mai","year":"2010","journal-title":"Front Biosci (Landmark Ed)"},{"key":"key20200713004456_b37-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"8263","DOI":"10.18632\/oncotarget.23862","article-title":"Preclinical evaluation of the PI3K\/Akt\/mTOR pathway in animal models of multiple sclerosis","volume":"9","author":"Mammana","year":"2018","journal-title":"Oncotarget"},{"key":"key20200713004456_b38-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"909","DOI":"10.3892\/ijo.2014.2525","article-title":"Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia (review)","volume":"45","author":"Evangelisti","year":"2014","journal-title":"Int J Oncol"},{"key":"key20200713004456_b39-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3892\/ijo.2015.2995","article-title":"Intravesical dual PI3K\/mTOR complex 1\/2 inhibitor NVP-BEZ235 therapy in an orthotopic bladder cancer model","volume":"47","author":"Matsushima","year":"2015","journal-title":"Int J Oncol"},{"key":"key20200713004456_b40-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.4049\/jimmunol.1600167","article-title":"Context-specific function of S6K2 in th cell differentiation","volume":"197","author":"Pai","year":"2016","journal-title":"J Immunol"},{"key":"key20200713004456_b41-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1167\/iovs.09-3974","article-title":"The PI3K\/Akt and mTOR\/P70S6K signaling pathways in human uveal melanoma cells: Interaction with B-Raf\/ERK","volume":"51","author":"Babchia","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key20200713004456_b42-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1007\/s10637-019-00733-3","article-title":"Lopinavir-NO, a nitric oxide-releasing HIV protease inhibitor, suppresses the growth of melanoma cells in vitro and in vivo","volume":"37","author":"Paskas","year":"2019","journal-title":"Invest New Drugs"},{"issue":"E2463","key":"key20200713004456_b43-etm-0-0-8716","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23102463","article-title":"Anticancer and differentiation properties of the nitric oxide derivative of lopinavir in human glioblastoma cells","volume":"23","author":"Basile","year":"2018","journal-title":"Molecules"},{"key":"key20200713004456_b44-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1002\/ijc.30529","article-title":"HIV-Protease inhibitors for the treatment of cancer: Repositioning HIV protease inhibitors while developing more potent NO-hybridized derivatives?","volume":"140","author":"Maksimovic-Ivanic","year":"2017","journal-title":"Int J Cancer"},{"key":"key20200713004456_b45-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1046\/j.1365-2249.1998.00604.x","article-title":"Blood levels of transforming growth factor-beta 1 (TGF-beta1) are elevated in both relapsing remitting and chronic progressive multiple sclerosis (MS) patients and are further augmented by treatment with interferon-beta 1b (IFN-beta1b)","volume":"113","author":"Nicoletti","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"key20200713004456_b46-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.3892\/ijmm.2016.2542","article-title":"Macrophage migration inhibitory factor promotes cardiac stem cell proliferation and endothelial differentiation through the activation of the PI3K\/Akt\/mTOR and AMPK pathways","volume":"37","author":"Cui","year":"2016","journal-title":"Int J Mol Med"},{"key":"key20200713004456_b47-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.drudis.2018.11.003","article-title":"Role of MIF and D-DT in immune-inflammatory, autoimmune, and chronic respiratory diseases: From pathogenic factors to therapeutic targets","volume":"24","author":"Gunther","year":"2019","journal-title":"Drug Discov Today"},{"key":"key20200713004456_b48-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.3892\/ijo.2015.3185","article-title":"Macrophage migration inhibitory factor involvement in breast cancer (Review)","volume":"47","author":"Richard","year":"2015","journal-title":"Int J Oncol"},{"key":"key20200713004456_b49-etm-0-0-8716","doi-asserted-by":"publisher","first-page":"17951","DOI":"10.18632\/oncotarget.24885","article-title":"Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach","volume":"9","author":"Mangano","year":"2018","journal-title":"Oncotarget"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T19:43:55Z","timestamp":1597261435000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2020.8716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,5]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,5,5]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2020.8716","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,5]]}}}